Loading company…
Kirkland-based genomics company that built gene expression tools and was sold to Merck & Co. in 2001.
Rosetta Inpharmatics focuses on genomic research and gene expression tools, along with bioinformatics and data management services for pharmaceutical companies and researchers. Founded in Kirkland, US, the company completed an IPO in August 2000 that raised USD 100.8 mn. It was sold to Merck & Co., Inc. in May 2001 for USD 620 mn, and its revenue in the most recent fiscal year was USD 10,459,232, with EBITDA of USD -31,013,554.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in